(Q45178235)

10 December 2017

title

Hsp70 gene transfer by adeno-associated virus inhibits MPTP-induced nigrostriatal degeneration in the mouse model of Parkinson disease (English)

1 reference

10 December 2017

1 reference

3

Hans-Peter Lipp

1 reference

10 December 2017

Zhizhong Dong

1

1 reference

10 December 2017

David P Wolfer

series ordinal

2

1 reference

10 December 2017

Hansruedi Büeler

series ordinal

4

1 reference

10 December 2017

publication date

1 January 2005

1 reference

10 December 2017

1 reference

10 December 2017

volume

11

1 reference

10 December 2017

issue

1

1 reference

10 December 2017

page(s)

80-88

1 reference

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

alpha-Synuclein locus triplication causes Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Parkin and the molecular pathways of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Early-onset Parkinson's disease caused by a compound heterozygous DJ-1 mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

DJ-1 has a role in antioxidative stress to prevent cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Molecular Pathways of Neurodegeneration in Parkinson's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Parkinson's disease: mechanisms and models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Caspase-11 mediates inflammatory dopaminergic cell death in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Molecular chaperones in the cytosol: from nascent chain to folded protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Protein degradation and protection against misfolded or damaged proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Negative regulation of the Apaf-1 apoptosome by Hsp70

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Heat-shock protein 70 antagonizes apoptosis-inducing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Chaperoning brain degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by instrastriatal 6-hydroxydopamine in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Are ubiquitination pathways central to Parkinson's disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Oxidative stress and genetics in the pathogenesis of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Rare genetic mutations shed light on the pathogenesis of Parkinson disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

7 January 2021

Pathways to Parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Genetic suppression of polyglutamine toxicity in Drosophila

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Analysis of heat-shock protein�70 gene polymorphisms and the risk of Parkinson?s disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Heat shock protein hsp70 overexpression confers resistance against nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Induction of heat shock protein 70 protects mesangial cells against oxidative injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Mitochondria are selective targets for the protective effects of heat shock against oxidative injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Animal models of Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Heat shock protein 72 modulates pathways of stress-induced apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Proteasome inhibition in oxidative stress neurotoxicity: implications for heat shock proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Protein misfolding, amyloid formation, and neurodegeneration: a critical role for molecular chaperones?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Novel tools for production and purification of recombinant adenoassociated virus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Dopamine-dependent neurodegeneration in rats induced by viral vector-mediated overexpression of the parkin target protein, CDCrel-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Extended analysis of path data from mutant mice using the public domain software Wintrack

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Transduction profiles of recombinant adeno-associated virus vectors derived from serotypes 2 and 5 in the nigrostriatal system of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

Understanding cell death in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.09.007

10.1016/J.YMTHE.2004.09.007

7 January 2021

Identifiers

DOI

1 reference

10 December 2017

1 reference